Clinical characterization of Staphylococcus schleiferi infections and identification of risk factors for acquisition of oxacillin-resistant strains in dogs: 225 cases (2003-2009).

OBJECTIVE To define clinical differences between coagulase-positive and coagulase-negative Staphylococcus schleiferi infections in dogs and to identify risk factors for the isolation of oxacillin-resistant S schleiferi. DESIGN Retrospective case series. ANIMALS 225 dogs (yielding 225 S schleiferi isolates). PROCEDURES Information obtained from affected dogs' medical records included isolate body site source, antimicrobial treatments, and primary disease. For each dog, the S schleiferi isolate was characterized and antimicrobial susceptibility data were recorded. Risk factors for infection based on coagulase status and for S schleiferi oxacillin resistance were investigated. RESULTS Allergic dermatitis was the most common underlying disease (111/225 dogs). Ears (102 [45%]) and skin (95 [42%]) were sources of most of the 225 isolates. Isolate coagulase status was not significantly associated with any patient-level factors. Of the 225 isolates, 129 (57%) were oxacillin resistant. Coagulase-negative isolates were more likely to be oxacillin resistant than were coagulase-positive isolates (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.1 to 3.0). Administration of penicillin-based or first-generation cephalosporin drugs (OR, 3.0; 95% CI, 1.8 to 5.9) and third-generation cephalosporins (OR, 3.7; 95% CI, 1.1 to 12.3) within 30 days prior to culture were risk factors for oxacillin resistance. CONCLUSIONS AND CLINICAL RELEVANCE Results suggested that coagulase-negative and coagulase-positive S schleiferi are potential pathogens in dogs and are often oxacillin resistant. Recent patient treatments with penicillin or cephalosporin were risk factors for oxacillin resistance. In clinical cases, full speciation of all Staphylococcus isolates should be performed and microbial treatments should be selected on the basis of results of susceptibility testing.

[1]  M. Faires,et al.  Methicillin-Resistant and -Susceptible Staphylococcus aureus Infections in Dogs , 2010, Emerging infectious diseases.

[2]  J. Ross Fitzgerald,et al.  The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and the emergence of meticillin resistance. , 2009, Veterinary dermatology.

[3]  G. Verschraegen,et al.  Role of coagulase-negative staphylococci in human disease. , 2009, Veterinary microbiology.

[4]  F. Shofer,et al.  Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi in dogs with healthy and inflamed skin. , 2008, Veterinary dermatology.

[5]  S. Alvarez,et al.  Case of Staphylococcus schleiferi subspecies coagulans endocarditis and metastatic infection in an immune compromised host , 2007, Transplant infectious disease : an official journal of the Transplantation Society.

[6]  Yoshikazu Tanaka,et al.  Reclassification of Phenotypically Identified Staphylococcus intermedius Strains , 2007, Journal of Clinical Microbiology.

[7]  R. Ferreira,et al.  Simplified and Reliable Scheme for Species-Level Identification of Staphylococcus Clinical Isolates , 2007, Journal of Clinical Microbiology.

[8]  B. Rohrbach,et al.  Prevalence of oxacillin- and multidrug-resistant staphylococci in clinical samples from dogs: 1,772 samples (2001-2005). , 2007, Journal of the American Veterinary Medical Association.

[9]  F. Shofer,et al.  Screening of Staphylococcus aureus, Staphylococcus intermedius, and Staphylococcus schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-04). , 2006, Veterinary dermatology.

[10]  T. Bannerman,et al.  Genotypic relatedness of staphylococcal strains isolated from pustules and carriage sites in dogs with superficial bacterial folliculitis. , 2006, American journal of veterinary research.

[11]  L. Frank,et al.  Isolation of Staphylococcus schleiferi from healthy dogs and dogs with otitis, pyoderma, or both. , 2005, Journal of the American Veterinary Medical Association.

[12]  P. Hsueh,et al.  Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents , 2005, International Journal of Antimicrobial Agents.

[13]  J. Kawano,et al.  Isolation and characterization of staphylococci from external auditory meatus of dogs with or without otitis externa with special reference to Staphylococcus schleiferi subsp. coagulans isolates. , 2005, The Journal of veterinary medical science.

[14]  J. García-Martínez,et al.  Epidemiology and Clonality of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Causing Bacteremia in a Tertiary-Care Hospital in Spain , 2005, Infection Control & Hospital Epidemiology.

[15]  L. Frank,et al.  Methicillin resistance of staphylococci isolated from the skin of dogs with pyoderma. , 2004, American journal of veterinary research.

[16]  L. Guardabassi,et al.  Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners. , 2004, Veterinary microbiology.

[17]  Y. Carmeli,et al.  Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients , 2003, Emerging infectious diseases.

[18]  L. Frank,et al.  Isolation of Staphylococcus schleiferi from dogs with pyoderma. , 2003, Journal of the American Veterinary Medical Association.

[19]  R. Venezia,et al.  Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. , 2002, The Journal of antimicrobial chemotherapy.

[20]  J. Freney,et al.  Isolation of Staphylococcus schleiferi subspecies coagulans from two cases of canine pyoderma , 2002, Veterinary Record.

[21]  J. Calvo,et al.  Clinical and Microbiological Characteristics of 28 Patients with Staphylococcus schleiferi Infection , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[22]  J. Calvo,et al.  Osteomyelitis Caused by Staphylococcus schleiferi and Evidence of Misidentification of ThisStaphylococcus Species by an Automated Bacterial Identification System , 2000, Journal of Clinical Microbiology.

[23]  D. Hooper,et al.  Induction of Fibronectin-Binding Proteins and Increased Adhesion of Quinolone-Resistant Staphylococcus aureus by Subinhibitory Levels of Ciprofloxacin , 2000, Antimicrobial Agents and Chemotherapy.

[24]  J. Pearman,et al.  Case of Staphylococcus schleiferi Endocarditis and a Simple Scheme To Identify Clumping Factor-Positive Staphylococci , 1999, Journal of Clinical Microbiology.

[25]  G. Lina,et al.  Staphylococcus schleiferi subsp.schleiferi Expresses a Fibronectin-Binding Protein , 1999, Infection and Immunity.

[26]  N. Crowcroft,et al.  Methicillin-Resistant Staphylococcus Aureus and Antimicrobial Use in Belgian Hospitals , 1999, Infection Control & Hospital Epidemiology.

[27]  D. Monnet.  Methicillin-Resistant Staphylococcus aureus and Its Relationship to Antimicrobial Use: Possible Implications for Control , 1998, Infection Control & Hospital Epidemiology.

[28]  H Lelièvre,et al.  Role of the preaxillary flora in pacemaker infections: a prospective study. , 1998, Circulation.

[29]  H. Chambers.  Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications , 1997, Clinical microbiology reviews.

[30]  D. Lloyd,et al.  A review of the biology of canine skin with respect to the commensals Staphylococcus intermedins, Demodex canis and Malassezia pachydermatis. , 1996, Veterinary dermatology.

[31]  Y. Benito,et al.  Clotting activity in Staphylococcus schleiferi subspecies from human patients , 1994, Journal of clinical microbiology.

[32]  T. Mitsuoka,et al.  Staphylococcus schleiferi subsp. coagulans subsp. nov., isolated from the external auditory meatus of dogs with external ear otitis. , 1990, International Journal of Systematic Bacteriology.

[33]  F. Grimont,et al.  Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., Two Species from Human Clinical Specimens , 1988 .

[34]  D. Morris,et al.  Genotypic relatedness and phenotypic characterization of Staphylococcus schleiferi subspecies in clinical samples from dogs. , 2011, American journal of veterinary research.

[35]  F. Koksal,et al.  Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey. , 2009, Microbiological research.

[36]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[37]  R. Gentry,et al.  BACTERIAL SKIN DISEASES , 1998 .

[38]  F. Vandenesch,et al.  Outbreak of Staphylococcus schleiferi wound infections: strain characterization by randomly amplified polymorphic DNA analysis, PCR ribotyping, conventional ribotyping, and pulsed-field gel electrophoresis. , 1998, Journal of clinical microbiology.

[39]  F. Goldstein,et al.  Trends in bacterial resistance to fluoroquinolones. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.